CNS Pharmaceuticals (CNSP) Institutional Ownership $0.10 -0.01 (-6.34%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for CNS Pharmaceuticals (NASDAQ:CNSP)CurrentInstitutional OwnershipPercentage14.02%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$9.21MNumber ofInstitutional Sellers(last 12 months)0 Get CNSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNSP Institutional Buying and Selling by Quarter CNS Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024Virtu Financial LLC94,246$34K0.0%+616.6%0.795% 2/13/2024Armistice Capital LLC122,000$155K0.0%N/A1.965% 1/17/2024 Smith Anglin Financial LLC50,000$64K0.0%N/A0.952% 8/7/2023Acadian Asset Management LLC22,292$49K0.0%N/A1.000% 7/12/2023FSM Wealth Advisors LLC16,334$38K0.0%N/A0.732% 9/17/2021Virtu Financial LLC20,745$41K0.0%-49.8%0.076% 8/13/2021Renaissance Technologies LLC432,109$847K0.0%-40.2%1.704% 8/13/2021Geode Capital Management LLC100,196$196K0.0%+64.8%0.395% 8/13/2021Vanguard Group Inc.599,309$1.18M0.0%+326.6%2.363% 8/11/2021Commonwealth Equity Services LLC20,000$39K0.0%N/A0.079% 5/19/2021Virtu Financial LLC41,310$99K0.0%N/A0.163% 5/18/2021Citadel Advisors LLC92,404$221K0.0%N/A0.364% 5/18/2021Jane Street Group LLC13,747$33K0.0%N/A0.054% 5/17/2021Goldman Sachs Group Inc.11,566$28K0.0%N/A0.046% 5/13/2021Renaissance Technologies LLC722,760$1.73M0.0%N/A2.850% 5/13/2021Bank of New York Mellon Corp43,659$104K0.0%N/A0.172% 5/12/2021Northern Trust Corp32,094$77K0.0%N/A0.127% 5/12/2021Geode Capital Management LLC60,784$145K0.0%N/A0.240% 2/16/2021Warberg Asset Management LLC14,000$25K0.0%N/A0.059% (Data available from 1/1/2016 forward) CNSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNSP shares? During the previous two years, the following institutional investors and hedge funds held shares of CNS Pharmaceuticals shares: Armistice Capital LLC ($155K), Smith Anglin Financial LLC ($64K), Acadian Asset Management LLC ($49K), and FSM Wealth Advisors LLC ($38K), Virtu Financial LLC ($34K).Learn more on CNSP's institutional investors. What percentage of CNS Pharmaceuticals stock is owned by institutional investors? 14.02% of CNS Pharmaceuticals stock is owned by institutional investors. Learn more on CNSP's institutional investor holdings. Which institutional investors have been buying CNS Pharmaceuticals stock? The following institutional investors have purchased CNS Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($122K), Virtu Financial LLC ($81.09K), Smith Anglin Financial LLC ($50K), Acadian Asset Management LLC ($22.29K), and FSM Wealth Advisors LLC ($16.33K). How much institutional buying is happening at CNS Pharmaceuticals? Institutional investors have bought a total of 291,720 shares in the last 24 months. This purchase volume represents approximately $16.70M in transactions. Related Companies LSB Institutional Ownership LGVN Institutional Ownership NAII Institutional Ownership DRRX Institutional Ownership CDIO Institutional Ownership ATHE Institutional Ownership LVTX Institutional Ownership EQ Institutional Ownership ENLV Institutional Ownership LPCN Institutional Ownership This page (NASDAQ:CNSP) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNSP Stock Alerts